Substitutionsmittel und Beikonsum bei Opiatabhängigen

Suchttherapie

Volumn 7, Issue 1, 2006, Pages 18-23

  Madlung, E ^a   Dunkel, D ^a   Haring, C ^a  

^a Psychiatrisches Krankenhaus des Landes Tirol Primariat B   (Germany)

Author keywords

consumption; Opioid addiction; slow release morphine; substitution

Indexed keywords

EID: 33847232303     PISSN: 14399903     EISSN: 1439989X     Source Type: Journal    
DOI: 10.1055/s-2006-926532     Document Type: Article

References (36)

1. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer, 1991
2. Farrell M, Ward J, Mattick R et al. Methadone maintenance treatment in opiate dependence: a review. BMJ 1994; 309: 997–1001
3. Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep 1998; 113: 107–115
4. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a metaanalysis. Addiction 1998; 93: 515–532
5. Mattick RP, Breen C, Kimber J et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003; 2: CD002209
6. Raschke P, Verthein U, Janczak H et al. Substitutionstherapie. Ergebnisse langfristiger Behandlung von Opiatabhängigen. In: Lambertus (Hrsg). Freiburg, 1994
7. Dyer KR, Wihte JM. Patterns of symptom complaints in methadone maintenance patients. Addiction 1997; 92: 1445–1455
8. Hunt DE, Lipton DS, Goldsmith DS et al. “lt takes your heart”: the image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int J Addict 1985; 20: 1751–1771
9. Longwell B, Betz T, Horton H et al. Weight gain and edema on methadone maintenance therapy. Int J Addict 1979; 14: 329–335
10. Longwell B, Kestler RJ, Cox TJ. Side effects in methadone patients: a survey of self-reported complaints. Int J Addict 1979; 14:485–494
11. Seidenberg A, Honegger U. Methadon, Heroin und andere Opioide. Medizinisches Manual für die ambulante opioidgestützte Behandlung. Bern: Hans Huber, 1998
12. Fischer B, Rehm J, Kim G et al. Eyes Wide Shut? - A Conceptual and Empirical Critique of Methadone Maintenance Treatment. Eur Addict Res 2005; 11: 1–14
13. Fischer B, Rehm J, Kirst M et al. Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health 2002; 12:228–234
14. Bamett PG. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction 1999; 94: 479–488
15. ÖBIG (Österreichisches Bundesinstitut für Gesundheitswesen). Bericht zur Drogensituation 2004. Wien, 2004
16. Dobler-Mikola A, Pfeifer S, Müller V et al. Vergleich Methadon- und Heroinverschreibung in der Schweiz. Suchttherapie 2000; 1: 63–66
17. Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 2003; 98: 7–22
18. Giacomuzzi SM, Ertl M, Riemer Y et al. Aktuelle Konsumformen bei Drogenabhängigkeit - Implikationen für Substitutionsprogramme in ambulanten Einrichtungen und bei behandelnden Ärzten. Wien Klin Wochenschr 2004; 116: 119–127
19. Gerra G, Ferri M, Polidori E et al. Long-term methadone maintenance effectiveness: psychosozial and pharmacological variables. Journal of Substance Abuse Treatment 2003: 25: 1–8
20. Uchtenhagen A. Substitutionsbehandlung. In: Uchtenhagen A, Zieglgänsberger W (Hrsg). Suchtmedizin. Konzepte, Strategien und therapeutisches Management. München, Jena: Urban & Fischer, 2000
21. Faggiano F, Vigna-Taglianti F, Versino E et al. Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev 2003; 3: CD002208
22. McGlothlin WH, Anglin MD. Long-term follow-up of clients of highland low-dose methadone programs. Arch Gen Psychiatry 1981; 38: 1055–1063
23. Strain EC, Bigelow GE, Liebson IA et al. Moderate-vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA 1999:281: 1000–1005
24. Affentranger P, Seidenberg A, Hämming R et al. Morphin: Ein Opioid mit Überraschungen. In: Rihs-Middel M.Jacobshagen N, Seidenberg A (Hrsg). Bundesamt für Gesundheit, Bern, Schweiz. Ärztliche Verschreibung von Betäubungsmitteln. Praktische Umsetzung und wichtigste Ergebnisse. Bern: Verlag Hans Huber, 2002
25. Kraigher D, Jagsch R, Gombas W et al. Use of Slow-Release Oral Morphine for the Treatment of Opioid Dependence. Eur Addict Res 2005; 11: 145–151
26. Amato L, Minozzi S, Davoli M et al. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 2004;4:CD004147
27. Wittchen HU, Apelt S, Christl B et al. Die Versorgungspraxis der Substitutionstherapie Opiatabhängiger (COBRA). Suchtmed 2004; 6: 80–87
28. Fischer G, Jagsch R, Eder H et al. Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 1999; 94:231–239
29. Eder H, Jagsch R, Kraigher D et al. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction 2005; 100: 1101–1109
30. Kraigher D, Ortner R, Eder H et al. Slow-release morphine hydrochloride for maintenance therapy of opioid dependence. Wien Klin Wochenschr 2002; 114:904–910
31. Mitchell TB, White JM, Somogyi AA et al. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction 2004; 99: 940–945
32. EMCDD (European Monitoring Centre for Drugs and Drug Addiction). Annual report on the state of the drugs problem in the European Union Office for Official Publications of the European Communities. Luxembourg, 2000
33. van den Brink W, Hendriks VM, Blankcn P et al. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 2003; 327: 310
34. Perneger TV, Giner F, del Rio M et al. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998:317: 13–18
35. Rehm J, Gschwend P, Steffen T et al. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001: 358: 1417–1423
36. Strang J, Marsden J, Cummins M et al. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome. Addiction 2000; 95: 1631–1645